Stock QLIFE QLIFE HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Qlife Holding AB

Equities

QLIFE

SE0013486552

Market Closed - Nasdaq Stockholm
Other stock markets
 17:00:00 02/07/2024 BST 		5-day change 1st Jan Change
0.0012 SEK +9.09% Intraday chart for Qlife Holding AB -29.41% -93.97%
07-02 Qlife Participates Research Trial for People Living with PKU and Gets Positive Data CI
06-03 Qlife Starts Clinical Trial in China with First Biomarker on Egoo Health CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Qlife participates research trial for people living with PKU and gets positive data
AQ
Qlife Participates Research Trial for People Living with PKU and Gets Positive Data
CI
Qlife Holding AB publishes 2023 annual report
AQ
Qlife starts clinical trial in China with first biomarker on Egoo Health
AQ
Qlife Starts Clinical Trial in China with First Biomarker on Egoo Health
CI
QLIFE HOLDING AB, Interim Report Q1, January to March 2024
AQ
Qlife Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Qlife Holding AB enters into an addendum with the holders of the company's convertible debentures and all outstanding convertible debentures are converted into shares
AQ
Qlife Places Danish Operational Company in Reconstruction Mode
MT
Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure
AQ
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership
MT
Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships
AQ
Qlife Signs Letter of Intent with Precision Biosensor
CI
Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.
AQ
Qlife Secures Core Patent for Egoo System in EU, UK Markets
MT
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom
CI
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology
CI
Qlife publishes prospectus due to upcoming rights issue of units
AQ
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QLIFE Stock
  4. News Qlife Holding AB